Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524717 | NSE Symbol : | ISIN : INE150C01011 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
26-May-2025	30-May-2025	Accounts	Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited (Standalone and Consolidated) Financial Results for the Quarter and Financial Year ended March 31 2025 and to consider recommendation of Final Dividend if any for the Financial Year ended March 31 2025. Board Meeting Outcome for Outcome Of Board Meeting The Board of Directors have recommended a dividend of Rs. 02.00/- (Two Rupees Only) per equity share for the Financial Year ended on 31st March, 2025. The said dividend, if declared at the ensuing Annual General Meeting, will be credited/dispatched to the eligible shareholders after the AGM within the limit as prescribed under the Companies Act, 2013 and other applicable laws. Information regarding Book closure/ Record date and dividend payment date will be informed in due course of time. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors, at its meeting held today i.e. Friday 30th May, 2025, Approval of Audited Financial Results For The Fourth Quarter And Year Ended 31st March, 2025, Recommendation of Dividend, appointment of Secretarial Auditor, Appointment of Cost Auditor, Appointment of Internal Auditor,Appointment of Scrutinizer (As Per BSE Announcement Dated on 30.05.2025)
24-Mar-2025	24-Mar-2025	Change in Auditors	Appointment of Secretarial Auditor for the financial year ended on 31/03/2025
03-Feb-2025	12-Feb-2025	Quarterly Results	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve Unaudited Standalone & Consolidated Financial Results For The Quarter ended on 31st December 2024 Unaudited Financial Results for the Quarter and Nine Months ended on 31-12-2024 (As Per BSE Announcement Dated on: 12/02/2025)
05-Nov-2024	12-Nov-2024	Quarterly Results	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve The Titan Biotech Ltd has informed BSE about the board meeting of the Company is scheduled to be held on 12th November 2024 inter alia to consider and approval of unaudited financial results for the quarter and half year ended on 30 September 2024. Unaudited Financial Results for 3 months ended 30th September, 2024 (As per BSE Announcement dated on 12/11/2024)
03-Sep-2024	03-Sep-2024	Change in Auditors	Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, the company want to inform the appointment of cost auditor
03-Aug-2024	13-Aug-2024	Quarterly Results	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Titan Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the Unaudited (Standalone and Consolidated) Financial Results for the quarter ended June 30 2024 Unaudited Results for quarter ended 30th June 2024 (As per BSE Announcement Dated on 13/08/2024)
18-May-2024	29-May-2024	Accounts	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Board Meeting for Audited Result Payment of Dividend and submission of Audited Results for year ended 31st March, 2024 (As per BSE Announcement Dated on 29/05/2024)
25-Apr-2024	25-Apr-2024	Change in Auditors	Appointment of Secretarial Auditor and Scrutinizer of the Company
31-Jan-2024	12-Feb-2024	Quarterly Results	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve unaudited financial results for quarter ended 31st December 2023. Unaudited Financial Results for quarter ended 31st December 2023 (As Per BSE Announcement Dated on: 12/02/2024)
26-Oct-2023	08-Nov-2023	Quarterly Results	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Unaudited Quarterly Financial Results for Quarter ended 30th September 2023 Unaudited Financial Results for quarter ended 30th September 2023 (As Per BSE Announcement Dated on 08/11/2023)
01-Sep-2023	01-Sep-2023	Change in Auditors	Appointment of Cost Auditor
31-Jul-2023	10-Aug-2023	Quarterly Results	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve unaudited quarterly financial results for quarter ended 30th June 2023 Unauidted Results for quarter ended 30th June, 2023 (As Per BSE Announcement dated on 10.08.2023)
15-May-2023	29-May-2023	Final Dividend	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve 1. Audited financial results for quarter and year ended 31st March 2023 2. Recommendation of dividend 3. Other Matters Audited Financial Results for Quarter and Financial Year ended 31st March, 2023 (As Per BSE Announcement dated on 29.05.2023)
12-Apr-2023	11-Apr-2023	Change in Auditors	Appointment of Secretarial Auditor of the Company
27-Jan-2023	04-Feb-2023	Quarterly Results	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2023 inter alia to consider and approve inter alia unaudited quarterly financial results for quarter ended 31st December 2022 Unaudited Financial Result for the Quarter & Nine months Ended on 31/12/2022 (As Per BSE Announcement Dated on 04.02.2023)

1 2 3

LOGIN HERE

Titan Biotech Ltd

Board Meeting